Gtcr LLC Has $182.62 Million Stake in Sotera Health Company $SHC

Gtcr LLC cut its position in shares of Sotera Health Company (NASDAQ:SHC) by 44.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,735,301 shares of the company’s stock after selling 10,000,000 shares during the period. Sotera Health accounts for 4.8% of Gtcr LLC’s portfolio, making the stock its 3rd largest holding. Gtcr LLC’s holdings in Sotera Health were worth $182,624,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of SHC. IFP Advisors Inc grew its holdings in Sotera Health by 1,105.6% during the fourth quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after purchasing an additional 1,371 shares during the period. Rothschild Investment LLC acquired a new stake in shares of Sotera Health in the fourth quarter valued at approximately $27,000. Root Financial Partners LLC boosted its stake in shares of Sotera Health by 217.5% during the 1st quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock worth $30,000 after acquiring an additional 1,455 shares during the period. EverSource Wealth Advisors LLC increased its holdings in shares of Sotera Health by 831.4% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after acquiring an additional 2,935 shares during the last quarter. Finally, Eurizon Capital SGR S.p.A. acquired a new position in shares of Sotera Health during the 4th quarter worth approximately $40,000. 91.03% of the stock is owned by institutional investors.

Insider Transactions at Sotera Health

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of Sotera Health stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 15.36% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have issued reports on SHC. UBS Group set a $19.00 price target on Sotera Health in a report on Wednesday, June 24th. The Goldman Sachs Group assumed coverage on shares of Sotera Health in a report on Friday, June 5th. They issued a “buy” rating and a $20.00 price objective on the stock. Barclays increased their price objective on shares of Sotera Health from $18.00 to $19.00 and gave the company an “overweight” rating in a research report on Wednesday, June 24th. Wall Street Zen downgraded shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Finally, Weiss Ratings upgraded shares of Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 9th. Eight research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $20.25.

Sotera Health Price Performance

Shares of NASDAQ:SHC opened at $17.35 on Friday. The firm has a market cap of $4.95 billion, a PE ratio of 42.32 and a beta of 1.76. The firm’s fifty day moving average is $16.65 and its 200-day moving average is $16.40. The company has a debt-to-equity ratio of 3.56, a quick ratio of 2.54 and a current ratio of 2.82. Sotera Health Company has a 52 week low of $11.00 and a 52 week high of $19.85.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.01. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The business had revenue of $280.05 million for the quarter, compared to analysts’ expectations of $270.78 million. During the same quarter in the prior year, the firm posted $0.14 earnings per share. The business’s quarterly revenue was up 10.0% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Sell-side analysts predict that Sotera Health Company will post 0.87 earnings per share for the current year.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.